Sign in

NCT07605468Not yet recruiting

Feasibility Study of a Remote Behavioral Dietary Intervention in Patients With Early to Intermediate AMD: Glucose Lowering for Vision Extension

Nonrandomized, Unmasked Feasibility Study of a Remote-based Behavioral Dietary Intervention in Patients With Early to Intermediate AMD: Glucose Lowering for Vision Extension (GLOVE)

Source: ClinicalTrials.gov · Last updated 26 May 2026

Brief summary (registry, in English)

The primary goal of the study is to test dietary intervention at glycemic control and carotenoid levels in participants with intermediate age-related macular degeneration.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
32 (estimated)
First submitted
18 May 2026
Start date
Jun 2026
Primary completion date
Jun 2028
Lead sponsor
Stanford University
NCT number
NCT07605468

What you commit to

  • Study type: Interventional
  • Planned participants: 32
  • From Jun 2026 to the primary completion date, Jun 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Use of statins, niacin or other lipid/cholesterol modifying medications

Other illness

  • Diabetes or medications used to treat diabetes or obesity (including GLP1 agonists, metformin, glyburide
  • Recent cancer (within past 3 years)

Lab values

  • HbA1c greater than 6.5%,

Other

  • Other retinal or ocular pathology (other than pseudophakia and/or refractive error (between -8 to +8 diopter spherical equivalence)

Who the study is looking for

  • Diagnosis of early to intermediate AMD with no history of retinal geographic atrophy (cRORA) or exudative disease
  • Eating a diet less healthy than average (Healthy Eating Index \[HEI\] score \<61) based on 3 24-hour dietary recalls
  • Access to a computer or smart phone for use in the behavioral meetings (we will provide loaners for those lacking a smart phone
  • Because the initial questionnaires (ASA24), surveys and informed consent will be on line and in English, only individuals with fluency in English will be included. (They do not need to list English as their primary language.)

Age in the registry: 55 years to 75 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
University of California, Los Angeles
Coordinator of this site? Confirm its status
Los AngelesUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.